Glycopegylated factor IX

Details for Australian Patent Application No. 2004296860 (hide)

Owner Novo Nordisk A/S

Inventors Bowe, Caryn; Defrees, Shawn; Panneerselvam, Krishnasamy; Bayer, Robert J.

Agent Allens Arthur Robinson

Pub. Number AU-B-2004296860

PCT Pub. Number WO2005/055950

Priority 60/539,387 26.01.04 US; 60/614,518 29.09.04 US; 60/623,387 29.10.04 US; 60/527,089 03.12.03 US; 60/592,744 29.07.04 US

Filing date 3 December 2004

Wipo publication date 23 June 2005

Acceptance publication date 22 April 2010

International Classifications

A61K 31/00 (2006.01)

C07K 1/00 (2006.01) General processes for the preparation of peptides

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/055950 Priority application(s): WO2005/055950

25 June 2009 Assignment before Grant

  Neose Technologies, Inc. The application has been assigned to Novo Nordisk A/S

22 April 2010 Application Accepted

  Published as AU-B-2004296860

19 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004296861-Methods and compositions for slowing aging

2004296855-Glycopegylated Granulocyte Colony Stimulating Factor